Introduction
Apoptosis is an energy-dependent process of cell suicide in response to a variety of stimuli and is characterized by a number of distinct morphological features and biochemical processes including cell shrinkage and partial detachment from substratum, plasma membrane blebbing, chromatin condensation and intra-nucleosomal cleavage and, ultimately, cell fragmentation into apoptotic bodies which are phagocytosed without provoking an inflammatory response (White, 1996 ; Vaux & Strasser, 1996) . Apoptosis is genetically controlled and plays roles in both embryonic development and tissue homeostasis in adults, where such programmed cell death is critical for the formation and maintenance of body form. Apoptosis also plays a protective role, eliminating cells which might prove harmful if they were to survive, e.g. removing cells harbouring mutations following irradiation or chemical insult which could lead to the emergence of cancer, and as a protection against virus infection.
A variety of physiological and non-physiological stimuli can provoke apoptotic cell death, among them, metabolic disturbances due to chemical insults, virus infections or developmental cues (Vaux & Strasser, 1996) . Although not all signals which initiate the apoptosis pathway are understood, in many, but not all, cases the tumour suppressor protein p53 is required to propagate the signal to commit suicide (Levine, 1997) . Members of the Bcl-2 family represent a major set point in the apoptotic pathway with cell fate resting, in many cases, with the dynamic balance between family members which promote and inhibit apoptosis (White, 1996 ; Rao & White, 1997) . Bcl-2-like family members appear to sit at a node in the apoptotic pathway at a point of integration for stimuli which provoke apoptosis and, in many but not all cases, appear to influence the activation of caspase family members [IL-1β-converting enzyme (ICE)-like proteases] which perform the ' execution ' phase of apoptosis, cleaving a number of cellular proteins to bring about destruction of cell structures (Clem & Duckett, 1997 ; Rao & White, 1997 ; Nagata, 1997) .
Several viral gene products affect apoptosis by interacting directly with components of the highly conserved biochemical pathway which regulates cell death (Fig. 1) . On the one hand it appears that viruses block apoptosis to prevent premature Author for correspondence : Vincent O'Brien.
Fax j44 141 942 6521. e-mail v.obrien!beatson.gla.ac.uk death of the host cell and so maximize virus progeny from a lytic infection or facilitate a persistent infection. On the other hand it appears that a growing number of viruses actively promote apoptosis ; viruses may perform both functions, the latter being the culmination of a lytic infection and serving to spread virus progeny to neighbouring cells while evading host inflammatory responses. Apoptosis may then contribute to the cytotoxicity associated with virus infections.
The purpose of this review is to summarize work describing the induction and suppression of apoptosis by viruses and viral products. Recent reviews also detail some of the work cited here .
Apoptosis as a virus defence mechanism
Higher vertebrates have evolved two major mechanisms to control virus infection, both of which rely on the elimination of infected cells by apoptosis. One is based on an immune response ; viral peptides are presented on the cell surface in complex with histocompatibility antigens which are recognized by cytotoxic T lymphocytes (see review by Oldstone, 1997) , which in turn deliver a signal to the infected cell to apoptose. The other defence mechanism is cellautonomous ; the infected cell senses the unscheduled activation of the cell cycle by viral proteins. One possible mechanism by which the infected cell can distinguish between cell cycle activation by viral proteins and that achieved by growth factors is that proliferation signals produced by growth factors are split into both cell-cycle-activating and apoptosissuppressing components (Harrington et al., 1994) . It is likely that DNA tumour virus proteins such as adenovirus E1A, human papillomavirus type 16 (HPV-16) E7 or simian virus 40 (SV40) large T antigen allow cell cycle activation but provide none of, or an incomplete complement of, the apoptosissuppressing signals. While the precise physiological and biochemical mechanisms remain to be determined, cell cycle activation elicited by these viral proteins is recognized as inappropriate and the cell eliminates itself by apoptosis (White, 1994 ; Eick & Hermeking, 1996) . In many cases this cell suicide has been shown to be mediated by the tumour suppressor protein p53, although its precise mechanism of action remains to be determined Lowe & Ruley, 1993) . It would appear that both p53-mediated transcriptional activation and a p53 function which does not require transcriptional activation play a role in apoptosis (Levine, Fig. 1 . Viral products which affect apoptosis. Components of the apoptotic pathway are depicted in schematic form as ovals. Viral proteins known to affect components of the pathway are shown in boxes. The reader is referred to the recent reviews cited in the text for more details on the process. Arrows do not necessarily indicate direct interactions. In addition to p53 inactivation, it is now clear that different viruses employ distinct mechanisms dependent and independent of p53 inactivation to block apoptosis (Table 1) . These virus strategies will be discussed below.
Viruses and viral products that block apoptosis Adenovirus
Human adenovirus provided the first indication that virus infection was dependent on the virus usurping control of apoptosis (Ezoe et al., 1981) . Virus mutants were discovered which produced a dramatic phenotype termed Cyt\Deg where infected cells died by a rapid cytolysis with accompanying degradation of host and viral DNA (Ezoe et al., 1981) . This effect was mapped to the functional loss of the E1B 19K protein, which has subsequently been shown to be homologous to Bcl-2 family members (Pilder et al., 1984 ; Chiou et al., 1994) .
The immortalizing and transforming properties of the E1A region of adenovirus are manifest only if the outcome of E1A expression that induces cell death is blocked. Foci of transformed cells formed among E1A-expressing cells degenerate and die by apoptosis, resulting in abortive transformation (Rao et al., 1992) . E1A-induced apoptosis requires functional p53, with expression of E1A leading to stabilization of p53, which in turn mediates apoptosis. E1A can provoke cell cycle entry through the physical interaction with pRb family members and through the modulation of the activity of other cellular proteins (reviewed in Bayley & Mymryk, 1994) but, unlike exogenous growth factors, provides incomplete signals and fails to suppress apoptosis. The E1A-induced, p53-mediated apoptosis can be blocked by either of the two main gene products of the E1B transcription unit, i.e. E1B 19K protein (Rao et al., 1992) or the E1B 55K protein (Debbas & White, 1993) and both proteins can co-operate with E1A for complete cell transformation. E1B 55K protein interferes with p53-mediated apoptosis by directly binding p53 but does not prevent p53 attachment to cognate DNA sequences (Yew et al., 1994) . E1B 19K and Bcl-2 are functionally interchangeable ; E1B 19K does not promote an elevation of Bcl-2 within cells, suggesting that it is a functional homologue of Bcl-2 (Huang et al., 1997) . In fact, E1B 19K interacts with three positive regulators of apoptosis from the Bcl-2 family : Bax (Han et al., 1996 a) , Bak (Farrow et al., 1995 a, b) and Bik (Han et al., 1996 b) in a manner analogous to Bcl-2. E1B 19K is also able to suppress cell death mediated by tumour necrosis factor alpha (TNF-α) and Fas ligand (FasL) (Huang et al., 1997) . This suggests that E1B 19K may regulate caspase activity, as recent evidence suggests that both TNF-α and FasL induce apoptosis by activation of caspases (reviewed in Nagata, 1997) . In support of this, it has been demonstrated that both Bcl-2 and E1B 19K prevent E1A-induced processing of CPP32 (caspase 3) and cleavage of the known caspase substrate poly(ADP-ribose) polymerase (Boulakia et al., 1996) .
Adenovirus encodes three additional proteins from the E3 transcription unit which function to block apoptosis. The E3 14n7K protein and the E3 10n4\14n5K heterodimer are able to prevent TNF-induced apoptosis, in part, by blocking TNFinduced arachidonic acid release (Krajcsi et al., 1996) . The viral heterodimer complex can inhibit TNF-α-induced translocation of phospholipase A2 to the plasma membrane (Dimitrov et al., 1997) -a translocation which has been shown to be necessary for TNF-induced apoptosis (Hayakawa et al., 1993) .
This heterodimeric complex also mediates the loss of cell surface expression of Fas and blocks Fas-induced apoptosis in infected cells (Shisler et al., 1997) . The E3 14n7K protein, in addition to its ability to block TNF-induced arachidonic acid release, is capable of a more direct inhibition of Fas-induced apoptosis by blocking caspase 8\FLICE activation through a physical interaction with this protease (Chen et al., 1998) . Recent results also point to other cellular targets for E3 14n7K. FIP-2 (14n7K interacting protein-2) was identified in a twohybrid screen using E3 14n7K as bait. FIP-2 is a novel protein containing leucine-zipper domains which is induced in response to TNF-α and, through direct interaction with E3 14n7K, can block the anti-apoptotic effect of the viral protein (Li et al., 1998) .
Another adenovirus protein, E4orf6, has been shown to block p53-mediated apoptosis (Moore et al., 1996) and to interact with p53 but at a distinct site from E1B 55K (Dobner et al., 1996) . Recent results demonstrate that E4orf6 is required to prevent p53 accumulation in adenovirus-infected cells (Querido et al., 1997) . Furthermore, E4orf6 and E1B 55K form a complex (Sarnow et al., 1984) , suggesting that multiple interactions between all three proteins may regulate p53 stability, maintaining low levels of p53 following infection (Querido et al., 1997) .
A novel anti-apoptotic protein, encoded by chicken adenovirus type 1, has been discovered. The gene encodes a 30 kDa protein, named GAM1, which is nuclear and can function like Bcl-2 and E1B 19K, blocking apoptosis induced by maintaining epithelial cells in suspension, TNF-α treatment or heterologous virus infection (Chiocca et al., 1997) . However, GAM1 shows no homology with any sequenced protein, but, like Bcl-2 and E1B 19K prevents activation of the transcription factor NF-κB induced by TNF-α treatment (Chiocca et al., 1997) .
African swine fever virus (ASFV)
This virus encodes a homologue to Bcl-2 (Neilan et al., 1993) and this protein, LMW5-HL\A179L, has been shown to suppress apoptosis (Afonso et al., 1996 ; Brun et al., 1996 ; Revilla et al., 1997) . ASFV also contains a homologue of the baculovirus inhibitor of apoptosis protein (IAP) (see below), which has been shown to be a late structural protein (Chacon et al., 1995) . However, this ASFV protein is not required for growth in vitro or for virus virulence and may not influence apoptosis (Neilan et al., 1997) .
Baculoviruses
Infection of some but not other insect cells with mutant strains of the prototypical baculovirus, Autographa californica multiple embedded nucleopolyhedrovirus (AcMNPV), results in apoptosis and a reduction in infectivity in vitro and in vivo (Clem et al., 1991) . These mutants contain alterations in the gene encoding the p35 protein and a p35 wild-type allele can complement the mutant viruses to restore infectivity (Hershberger et al., 1992) . The p35 protein can inhibit developmental cell death in nematodes and insects as well as neuronal cell death following growth factor withdrawal and Fas-and TNF-α-induced death in mammalian cells (reviewed in Clem et al., 1996) , suggesting that p35 targets a conserved component of the cell death machinery. The p35 protein has been shown to function as an inhibitor of phylogenetically diverse caspases, forming a stable complex with the active enzyme (Bump et al., 1995) . p35 has recently been shown to inhibit apoptosis by targeting a caspase activity induced by virus infection of insect host cells (Bertin et al., 1996) .
A second group of baculovirus genes, iap (inhibitor of apoptosis) from Orgia pseudotsugata polyhedrosis virus and Cydia pomonella granulosis virus also prevent cell death resulting from infection with AcMNPV p35 mutants (Crook et al., 1993) . IAPs prevent apoptosis induced by multiple signals in diverse organisms, suggesting that they act at a conserved step in the apoptosis pathway (Clem & Duckett, 1997) . These proteins contain a C3H4 (RING) zinc finger at the C terminus (Crook et al., 1993) . Various IAPs also show homology near the N terminus, which is a double repeat of a cysteine\
histidine-rich motif, termed a baculovirus IAP repeat (BIR). Both RING and BIR regions are required for anti-apoptotic function and are involved in protein-protein interactions (Clem & Miller, 1994 ; Clem & Duckett, 1997) .
A recent study has demonstrated that baculovirus IAPs can inhibit apoptosis in mammalian cells provoked by expression of caspases (Hawkins et al., 1996) , while another has demonstrated that IAPs function at or upstream of baculovirus p35 caspase inhibitor (Manji et al., 1997) , putting these molecules at or upstream of caspases in the cell death cascade.
Indeed, recent data indicates that one of the cellular IAPs physically and functionally interacts with at least two caspases to block their function (Devereaux et al., 1997) , while baculovirus IAPs can block activation of Sf caspase 1 from insect cells (Seshagiri & Miller, 1997) . Several Drosophila and mammalian homologues of the viral IAP proteins have been characterized and also contain RING and BIR sequence motifs (Hay et al., 1995 ; Liston et al., 1996 ; Duckett et al., 1996) . As two of these molecules where detected as a result of interactions with TNF receptor (TNFR)-TNFR-associated factor (TRAF) signalling components, it has been suggested that they function to block apoptosis through preventing activation of caspases downstream of TNF and Fas signalling pathways (Rothe et al., 1995) , although their mechanism(s) of action remains obscure.
Cytomegalovirus
Human cytomegalovirus encodes two immediate early gene products which independently can block apoptosis (Zhu et al., 1995) . These two gene products, IE1 and IE2 are transcription factors. IE2 binds to the TATA box binding protein, pRb and p53 (Hagemeier et al., 1994 ; Speir et al., 1994 ; Sommer et al., 1994) . IE2 has been shown to repress p53 transcriptional activity and this could account for its ability to inhibit apoptosis.
A recent report suggests that cytomegalovirus may target p53 in infected human endothelial cells. There is a cytoplasmic sequestration of p53, which may undermine the ability of this protein to mediate induction of apoptosis as infected cells are resistant to apoptosis upon serum withdrawal (Kovacs et al., 1996) .
Epstein-Barr virus (EBV)
This herpesvirus is the causative agent of infectious mononucleosis and is also associated with the human malignancies Burkitt's lymphoma and nasaopharyngeal carcinoma. EBV normally establishes a persistent infection in circulating B lymphocytes (Gratama et al., 1988 ; Yao et al., 1989) . For infection to persist, EBV infects long-lived memory B cells and\or must extend the limited life span of infected cells. Virus-induced entry of infected cells into the long-lived pool could be very important for virus persistence, since only a very small proportion of B cells are selected into the memory cell population by physiological means (MacLennan, 1994) . This blockage of the normal programmed B cell death by EBV requires the activation of genes which protect B cells from apoptosis (Gregory et al., 1991) . This protection depends on the expression of EBV latent membrane protein 1 (LMP1), which operates, in part, to up-regulate expression of Bcl-2 (Henderson et al., 1991) . LMP1 can interact with components of the TNF and Fas signalling cascade (Moslalos et al., 1995 ; Devergne et al., 1996) . Although LMP1 up-regulates p53 expression, it inhibits p53-mediated apoptosis (Okan et al., 1995) , at least in part, by up-regulating expression of A20, a cellular RING finger protein with anti-apoptotic activity (Opipari et al., 1992 a, b ; Fries et al., 1996) , which itself may modulate TNFR signalling by binding to TRAFs 1 and 2 (Song et al., 1996) . A20, together with Bcl-2, is also up-regulated in B cells by signalling through CD40, a cell-surface protein which has been shown to be important for promoting growth and survival of these lymphocytes (Laman et al., 1996) . LMP1 then acts like CD40 in that they both activate overlapping biochemical pathways to achieve their effects, although it is becoming clear that they interact with different TRAFs . LMP1 and CD40 are not related except for a PxQxT\S motif important for interaction with TRAFs (Devergne et al., 1996) . A model is emerging in which LMP1 associates with heteroaggregates of TRAF1\TRAF2 and these complexes function to recruit cellular IAP proteins to promote cell survival (Uren et al., 1996) . EBV encodes two other proteins which bind p53 and may play a role in blocking apoptosis. One is EBNA-5, which can also interact with pRb and so may promote de-regulation of the cell cycle and suppress apoptosis (Szekely et al., 1993) . The other is BZLF1, which appears to play a role in the switch from latent to lytic infection (Zhang et al., 1994 ; Daibata et al., 1996) and may also promote the survival of cells by modulating NF-κB, as it has been shown to interact with the p65 subunit of this transcription factor (Petropoulos et al., 1996) . NF-κB is a pleiotropic transcription factor, also activated by ' death receptors ' (TNF superfamily members), and has recently been shown to block apoptosis through induction of cellular genes, some of which exert an anti-apoptotic effect, e.g. A20 (see above).
Lytic infection of B cells by EBV appears to culminate in apoptosis of infected cells and release of virus progeny (Kawanishi, 1993) . One of the proteins involved in the lytic cycle of infection, BHFR1, has regions of homology with Bcl-2 (Henderson et al., 1993) and therefore has a suggested functional similarity. Indeed, BHFR1 can protect against apoptosis provoked by serum depletion, ionophore treatment (Henderson et al., 1993) , DNA damage or apoptosis induced by infection with an adenovirus mutant defective in E1B 19K function (Tarodi et al., 1994) , and can protect intestinal epithelial cells from apoptosis induced by TNF-α or Fas stimulation (Kawanishi, 1997) . Like E1B 19K, BHFR1 may function to limit apoptosis during infection to maximize virus progeny production.
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Hepatitis viruses
The pX protein from hepatitis B virus (HBV) has been shown to complex with p53, inhibiting sequence-specific DNA binding in vitro and p53-mediated transcriptional activation in vivo, and to inhibit p53-dependent apoptosis .
The hepatitis C virus (HCV) core protein has recently been shown to block apoptosis resulting from DNA damage or inappropriate expression of c-myc (Ray et al., 1996) . This protein regulates transcription of cellular and viral genes and has recently been shown to repress transcription from the p53 promoter, suggesting that repression of p53 expression might underlie the observed ability of this protein to block apoptosis (Ray et al., 1997) .
Herpesviruses
Herpesviruses other than CMV and EBV code for antiapoptotic functions. Herpes simplex virus type 1 contains a gene, γ " 34.5, which is not required for virus replication in culture but has been shown to prevent neuroblastoma cells from switching off protein synthesis, which is associated with neuronal apoptosis (Chou & Roizman, 1992) . Furthermore, γ " 34.5 is essential for neurovirulence in infected animals (Chou et al., 1990) . These results suggest that this protein functions to block apoptosis in infected neurons, leading to a productive infection.
HSV-1 also encodes a protein serine\threonine protein kinase, Us3, which can block apoptosis induced by virus infection (Leopardi et al., 1997) .
Herpesvirus saimiri encodes a Bcl-2 homologue, the product of ORF16, which can block apoptosis induced by heterologous virus infection (Smith, 1995 ; Nava et al., 1997) . The ORF16 product can form heterodimers with Bcl-2, Bax and Bak, but does not contain a BH3 region, suggesting that this conserved region within the Bcl-2 is dispensable for antiapoptotic activity (Nava et al., 1997) .
A recently discovered herpesvirus aetiologically associated with Kaposi's sarcomas, KSHV, contains a Bcl-2 homologue that can suppress Bax cytotoxicity in both human and yeast cells (Sarid et al., 1997) and block apoptosis resulting from heterologous virus infection (Cheng et al., 1997) . The overall homology of this protein, KSbcl-2, with Bcl-2 is low but regions of homology are concentrated within the Bcl-2 homology regions 1 and 2 (BH1, BH2) (Cheng et al., 1997) . KSbcl-2 does not homodimerize, nor does it form dimers with other Bcl-2 family members and it has been suggested that it may escape the negative regulatory effects of Bax and Bak proteins (Cheng et al., 1997) . Like the ORF16 gene product of herpesvirus saimiri, KSbcl-2 does not contain a BH3 region, again suggesting that this region is not required for antiapoptotic activity (Cheng et al., 1997) .
A family of proteins has been discovered, members of which prevent the activation of caspase 8 and FLICE (FADDlike ICE) (Muzio et al., 1996) and are associated with the death receptors (Bertin et al., 1997 ; Thome et al., 1997) . These viral FLICE-like inhibitory proteins, or vFLIPs, contain two deatheffector domains which interact with the adapter protein FADD (Fas-associated death domain protein), preventing recruitment and activation of FLICE (reviewed in Nagata, 1997) . These vFLIP family members are present in bovine, equine and human gammaherpesviruses, including KSHV (Bertin et al., 1997 ; Thome et al., 1997) . Cells expressing vFLIPs are protected from apoptosis induced by Fas activation or by activation of the related ' death receptors ' TRAMPS and TRAIL-R (Thome et al., 1997) .
Papillomaviruses
Studies on the effects on apoptosis of E6 and E7 proteins from HPV types associated with squamous cell carcinoma (HPV-16 and -18) have been performed mainly using transgenic mice expressing E6, E7 or both papillomavirus proteins. HPV-16 E7 mice show extensive apoptosis in retinal photoreceptors (Howes et al., 1994) and in the lens of the eye (Pan & Griep, 1994) .
E7, like adenovirus E1A, binds the hypophosphorylated forms of the pRb family members, leading to release of E2F transcription factors (Morris et al., 1993 ; Lam et al., 1994) . E7, like E1A, also displays an ability to provoke apoptosis which is both p53-dependent and -independent (Pan & Griep, 1995) , and since pRb-null mice show the same pattern of apoptosis it has been suggested that E7 functions, primarily, to promote functional loss of pRb.
E7 can also abrogate p53-induced cell cycle arrest after DNA damage, but cannot prevent subsequent apoptosis (Wang et al., 1996 ; Hickman et al., 1997) . Interestingly, in mice expressing both HPV-16 E7 and E6, or only E6, there is substantially less apoptosis than in mice transgenic for E7 alone (Pan & Griep, 1995) . In contrast, there is a much higher incidence of tumour formation in mice expressing both E6 and E7 proteins (Pan & Griep, 1995) .
The E6 protein can block apoptosis by binding to p53 and targeting this tumour suppressor for proteolysis via the ubiquitin pathway (Werness et al., 1990 ; Scheffner et al., 1990) . E6 functions in a ternary complex with a protein, E6-AP, a ubiquitin protein ligase, to facilitate p53 degradation, thus rendering cells effectively null for p53 (Scheffner et al., 1990) .
Using a human epithelial cell line transformed with HPV-16 E6 and\or E7 it has been demonstrated that apoptosis occurs in response to γ-irradiation in E7 but not E6 or E6\E7 cells or in the parental cell line (Puthenveettil et al., 1996) . This cell death required p53, suggesting that E7 primes the cells for apoptosis through a p53-dependent pathway (Puthenveettil et al., 1996) . This is consistent with the observation that cells from E7 transgenic mice have higher levels of p53 (Pan & Griep, 1995) .
The prototypical E5 protein from bovine papillomavirus type 1 (BPV-1) can prevent cell death after IL-3 withdrawal
when expressed in an IL-3-dependent cell line (Goldstein et al., 1994 ; Sparkowski et al., 1996) . A direct investigation of the ability of BPV-1 E5 to block apoptosis remains to be undertaken ; however, BPV-4 E8, an E5 family member, when expressed in mouse fibroblasts, can inhibit apoptosis following treatment with ultraviolet light (V. O'Brien & M. S. Campo, unpublished observations). It is not known if E5 proteins from HPVs can alter cellular responses to apoptosis inducers, although HPV-16 E5 can co-operate with E7 to stimulate proliferation of primary cells and increase viral gene expression (Bouvard et al., 1994 ; Valle & Banks, 1995) , perhaps, in part, by diminishing apoptosis resulting from E7 expression.
Poxviruses
The cowpox cytokine response modifier (crmA) gene product is a specific inhibitor of caspases and acts to block or delay apoptosis in response to TNF-α (Miura et al., 1995) , Fas signalling (Talley et al., 1995) or cytotoxic T lymphocytes (Tewari et al., 1995) .
Vaccinia virus also blocks apoptosis induced by TNF-α or Fas signalling. The gene providing this capability, SPI-2, has recently been shown to encode a protein with high homology to CrmA (Dobbelstein & Shenk, 1996 ; Kettle et al., 1997) . The rabbit poxvirus, myxomavirus, the causative agent of myxomatosis in the European rabbit, can also inhibit apoptosis, and two gene products have been implicated in this : T2 and M11L. While T2 encodes a secreted protein which shares homology with TNF receptors, M11L is a novel transmembrane protein which appears to function to restrict infiltration of inflammatory cells into infected sites in vivo (Graham et al., 1992 ; Opgenorth et al., 1992 ; Macen et al., 1996) .
The anti-apoptotic activity of T2 protein expression could not be duplicated by addition of exogenous T2 to T cells infected with a virus defective for T2 expression, demonstrating that an intracellular form of T2 contributes to its antiapoptotic activity (Macen et al., 1996) . Recent results demonstrate that separate domains of T2 are responsible for extracellular TNF-α binding and intracellular inibition of apoptosis (Schreiber et al., 1997) .
Another poxvirus, Molluscum contagiosum, encodes a vFLIP protein that can interact with FADD and prevent caspase activation (Thome et al., 1997) . This protein, like gammaherpesvirus vFLIPs can inhibit apoptosis provoked by activation of TNFR or Fas (Thome et al., 1997) .
SV40
The large T antigen (Tag) of SV40, like adenovirus E1A and HPV-16 E7, binds the hypophosphorylated forms of the pRb family members but in addition can bind and inactivate p53. Using transgenic animals, it has been shown that Tag can block p53-dependent but not p53-independent apoptosis (McCarthy et al., 1994) . Expression of a mutant form of Tag that cannot Large T antigen bind p53 but retains its ability to interact with pRb leads to slower tumour development, accompanied by a high apoptotic index within the tumours, compared with animals transgenic for wild-type Tag . In addition, in lens fibre cells expression of a truncated Tag, which binds pRb but not p53, does not lead to tumour formation, while full-length Tag is sufficient to induce tumour formation (Fromm et al., 1994) . In vitro and in vivo, Fas-dependent apoptotic response in hepatocytes expressing Tag is significantly diminished compared to normal hepatocytes (Rouquet et al., 1995) . These results are consistent with Tag-mediated suppression of apoptosis leading to more aggressive tumour formation. In cell lines immortalized with a temperature-sensitive Tag, apoptosis is induced at the non-permissive temperature and suggests that cell death is induced as a consequence of p53 release from sequestration by Tag (Yanai & Obinata, 1994) . Recent work has directly implicated Tag in suppressing cell death induced by caspase expression and this protective effect is antagonized by p53 (Jung & Yuan, 1997) . However, a nontransforming form of Tag which cannot bind p53 is also capable of protecting rodent fibroblasts from apoptosis, suggesting that the ability of Tag to block apoptosis is not wholly dependent on inactivation of p53 (Conzen et al., 1997) . One domain in Tag essential for blocking apoptosis has greater than 60 % homology with the BH1 region of the Bcl-2 family, which is necessary for the anti-apoptotic activity of Bcl-2 and adenovirus E1B 19K proteins (Conzen et al., 1997) .
Viruses and viral products that induce apoptosis
As mentioned above, apoptosis induction represents a method by which viruses can induce host cell death while limiting inflammatory and other immune responses. This appears to represent an important mechanism for nonenveloped, non-lytic viruses. Much less information is available on this process of virus-induced apoptosis, although in some cases this function can be ascribed to specific viral proteins (Table 2 and text below). It is possible to speculate that virusinduced apoptosis may be an important mechanism of efficient dissemination of progeny.
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Adenovirus
As discussed earlier, the E1A proteins can induce apoptosis when expressed in cell lines in the absence of other adenovirus proteins. However, adenovirus appears to code for proteins which function to induce apoptosis at later stages of a natural infection, suggesting that E1B 55K and 19K protective effects are overcome. A gene product from the E3 complex has recently been implicated in adenovirus-associated cell death. The E3 11n6K protein, termed the adenovirus death protein (ADP), is expressed during late stages of infection and is required for efficient release of virus from infected cells (Tollefson et al., 1996 a, b) . However, it has not been established that this protein promotes apoptosis in host cells.
A co-operative interaction between E1A and one or more products of the E4 transcription complex has been demonstrated to be responsible for apoptosis in cells lacking functional p53 (Marcellus et al., 1996) .
Alphavirus
The prototypic alphavirus, Sindbis virus, replicates lytically in a variety of mammalian cell lines and lytic replication appears to be due to the induction of apoptosis (Levine et al., 1993) . This induction of apoptosis has also been shown to contribute to the pathogenicity of infection. Neurons of infected neonatal mice die by apoptosis, and the mice develop a fatal encephalitis as a result of virus infection (Levine et al., 1996) . The gene product(s) responsible for this effect have not yet been determined.
Chicken anaemia virus (CAV)
CAV-infected cells die in vitro and in vivo by a process of cell death greatly resembling apoptosis (Jeurissen et al., 1992 ; Noteborn et al., 1994) , while a single CAV protein is capable of inducing apoptosis in osteosarcoma cells independent of p53 function (Zhuang et al., 1995) . How this protein, VP3, termed apoptin, functions remains unknown, although it appears to induce apoptosis only in transformed cells (Danen van Oorschot et al., 1997) .
Human immunodeficiency virus type 1 (HIV-1)
Patients with HIV-1 infection are characterized by a selective depletion of a subset of T lymphocytes, CD4 + T cells, which leads eventually to immunosuppression. It was first proposed that the pathology of HIV disease may result from an inappropriate triggering of apoptosis (Ameisen & Capron, 1991) . This pathological activation of T cells might represent one of the principal causes of the progressive CD4 + T cell loss typical of AIDS but is by no means the only possible explanation for the phenomenon. T cells from asymptomatic HIV patients are sensitive to apoptosis induced by activation through the T cell receptor (Groux et al., 1992) and lymphocytes infected in vitro soon die by apoptosis, while infected cells from HIV patients die by apoptosis when placed in culture (Meyaard et al., 1992) . The T cell depletion observed in HIV patients is brought about, at least in part, by induction of apoptosis via HIV-1 Tat protein, which functions to upregulate FasL, which in turn activates the Fas receptor (see Fig.  1 ) (Westendorp et al., 1995) . Overexpression and release of FasL leads to apoptosis in infected and uninfected cells (Finkel et al., 1995) . Tat has also been shown to cause a downregulation of Bcl-2 expression, concurrently causing an upregulation of Bax when expressed in various haematopoietic cell lines (Sastry et al., 1996) .
The viral gp120 and gp41 proteins may also promote apoptosis in infected and uninfected CD4 + cells (Finkel et al., 1995 ; Tuosto et al., 1995 ; Westendorp et al., 1995 ; Cottrez et al., 1997) . In addition, direct cytotoxic effects have been reported following expression of the HIV aspartic acid-directed protease in cultured cells (Strack et al., 1996) . Apoptosis mediated by the HIV protease is preceded by proteolysis of Bcl-2 (Strack et al., 1996) . In addition, inhibition of caspases can enhance HIV replication (Chinnaiyan et al., 1997) , suggesting that the HIV protease may play a key role in inhibiting apoptosis associated with virus infection.
Papillomaviruses
The viral transcription factor, E2, plays a key role in the virus life cycle and is often lost upon cell transformation and deleted in most HPV-associated cancers, where viral DNA is integrated into the host genome and the E2 gene is disrupted. This is consistent with a model in which E2 inhibits the transforming activity of the virus (E5, E6 and E7 expression), allowing a productive virus life cycle.
A recent report has demonstrated that HPV-18 and BPV-1 E2 proteins can induce apoptosis when expressed in HeLa cells, in part by restoring p53 functions as a result of E2-mediated repression of E6 expression (Desaintes et al., 1997) .
Parvoviruses
The B19 human parvovirus promotes apoptosis and this has been attributed to the expression of the non-structural protein (NSP) (Ozawa et al., 1988 ; Morey et al., 1993) . NSPs from murine and human viruses promote cell death when expressed in isolation in cell lines (Caillet-Fauquet et al., 1990) . The mode of action of NSP remains unknown, although it does appear to be a nuclear protein capable of binding DNA (Cotmore & Tattersall, 1988 ; Cotmore et al., 1995) and can alter the synthesis and phosphorylation of a number of cellular proteins (Anouja et al., 1997) .
Porcine reproductive and respiratory syndrome virus (PRRSV)
PRRSV induces apoptosis during the normal infection cycle (Suarez et al., 1996) . The viral product responsible for promoting apoptosis has been determined to be the p25 membrane glycoprotein encoded by ORF5 (Meulenberg et al., 1995 ; Suarez et al., 1996) . This protein can induce apoptosis that cannot be blocked by overexpression of Bcl-2, suggesting that it acts downstream of this anti-apoptotic factor (Suarez et al., 1996) .
Other viruses
An increasing number of viruses have been reported to induce apoptosis both in vitro and in vivo , but it is still unclear in many of these cases which viral gene products are involved in inducing apoptosis.
Perspective
The suicide of virally infected cells through apoptosis serves to limit infection and spread of progeny, affording the host organism some degree of protection against infection. Viruses have been under great selective pressure to evolve mechanisms to block apoptosis, at least during early stages of infection ; this affords a selective advantage to the virus, allowing it to replicate, spread and maintain persistent infections.
Much information has been obtained about the biochemical processes that are involved in the execution of apoptosis using virally encoded apoptosis inhibitors as tools to dissect these processes. As details of the infectious processes of more viruses become known then more information on the regulation and integration of the apoptotic pathways will be revealed. Viral inhibitors such as vFLIPS should be very informative and point to cellular homologues which regulate apoptosis through death receptors, while EBV LMP1 protein has provided insights into CD40 function and signalling. IAP proteins are part of a wider family encompassing cellular proteins which will probably prove to be key regulators of apoptotic pathways.
Many viruses induce apoptosis and the virus functions responsible for this induction are currently being characterized. They will yield valuable information on the induction of apoptosis during lytic infection and may provide opportunities for drug intervention for clinically important virus infections.
Continued research into how viruses regulate apoptosis may be of direct value in developing new treatments for diseases associated with an inappropriate occurrence of apoptosis (AIDS, neurodegenerative disorders), e.g. by utilizing viral proteins which suppress apoptosis and prolong the life span of cells. Conversely, viral products which promote apoptosis may be of use for treating diseases associated with a failure to trigger appropriate apoptosis (auto immune disorders, cancer), e.g. viral death inducers could be adapted to selectively kill cancer cells. As several viruses kill cells by promoting p53-independent apoptosis, their gene products might be adapted for use in killing cancer cells, many of which have non-functional p53.
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